Trials / Sponsors / Epigenetix, Inc.
Epigenetix, Inc.
Industry · 1 registered clinical trial — 1 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Recruiting | Dual BET and CBP/p300 Inhibitor in Patients With Targeted Advanced Solid Tumors and Hematological Malignancies Castrate Resistant Prostate Cancer, NUT Carcinoma, Chronic Myelomonocytic Leukemia | Phase 1 | 2022-12-21 |